AI assistant
Sending…
Riot Platforms, Inc. — Director's Dealing 2012
Jun 29, 2012
30793_dirs_2012-06-29_1abbf177-e4fe-4a83-ad8e-e86e0039e843.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-06-28
Reporting Person: MCGONEGAL JEFFREY (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-28 | Common Stock | P | 5000 | $1.919 | Acquired | 13072 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 500 | Indirect |
| Common Stock | 50 | Indirect |
Footnotes
F1: Reflects one-for-six reverse stock split effected on June 20, 2012.
More from Riot Platforms, Inc.
Annual Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Feb 4
Regulatory Filings
2026
Jan 16
Board/Management Information
2026
Jan 5